All Posts tagged Papers

Retina Vitreous Resource Center Update [March 2014]

It is the intent of this Update to provide you with information that is practical and useful in answering your patient’s questions in your clinical practice. To that end, we present new and emerging data regarding the studies being done with antiangiogenic agents, combination therapies, pharmacological and surgical management of age-related macular degeneration. We will also include review of gene testing and gene therapy, vitamin therapy for age-related macular degeneration, emerging developments in ocular imaging, artificial vision, diabetic retinopathy update, and an induced pluripotent stem cell update.

In addition to cutting edge research information, clinical findings that are important signs to recognize when following up on patients who have had retinal detachment surgery, treatments for age-related macular degeneration, retinal vein occlusions, and other retinal diseases will be discussed. Emphasis will be placed on clinical signs that are important for re-referral to a retina subspecialist.

Practical application to your daily practices will be our focus so we can all provide the most up-to-date information and care to our patients. Additionally, distilling the research frontiers with the greatest potential for clinical applicability will enable us to give hope to our patients with severe debilitating diseases.

We encourage feedback on ways we can improve our effort to meet your educational and practice needs.

Update [March 2014]
Dr. Radtke’s current newsletter to patients and colleagues.
(729K PDF)

Page

Acknowledgement of Our Research on Retinal Transplantation

Paul S. Baker, M.D., and Gary C. Brown from the Retina Service, Wills Eye Institute, Jefferson Medical College, in Philadelphia, Pennsylvania, wrote an article “Stem-cell therapy in retinal disease” for Current Opinion in Ophthalmology 2009; 20:175-181. They stated on page 178 of the article:

Although some studies were unable to demonstrate any positive effect on vision, other patients transplanted with fetal retinal sheets showed improved visual acuity over time (up to 6 years) [57**, 58].

The unprecedented double starring of our article in the reference meant “of outstanding interest.”

Page

References and Recommended Reading

Papers of particular interest, published within the annual period of review, have been highlighted as:
*of special interest
**of outstanding interest

Additional references related to this topic can also be found in the Current World Literature section in this issue (p. 226).

Radtke ND, Aramant RB, Petry HM, et al. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol 2008; 146:172-182.

This study demonstrates the safety and clinical benefit of retina RPE grafts in human subjects with retinal degeneration. Visual improvement was observed in seven of ten patients (three retinitis pigmentosa and four AMD).

Radtke ND, Aramant RB, Seiler MJ, et al. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch Ophthalmol 2004; 122:1159-1165.

We were honored that our work received such recognition from these esteemed professors.

Page